Cargando…
Dapagliflozin attenuates cardiac remodeling and dysfunction in rats with β-adrenergic receptor overactivation through restoring calcium handling and suppressing cardiomyocyte apoptosis
Background: Long-term β-adrenergic receptor (β-AR) activation can impair myocardial structure and function. Dapagliflozin (DAPA) has been reported to improve clinical prognosis in heart failure patients, whereas the exact mechanism remains unclear. Here, we investigated the effects of DAPA against β...
Autores principales: | Liu, Tao, Wu, Jinchun, Shi, Shaobo, Cui, Bo, Xiong, Feng, Yang, Shuang, Yan, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437211/ https://www.ncbi.nlm.nih.gov/pubmed/37589258 http://dx.doi.org/10.1177/14791641231197106 |
Ejemplares similares
-
Dapagliflozin reduces the vulnerability of rats with pulmonary arterial hypertension-induced right heart failure to ventricular arrhythmia by restoring calcium handling
por: Wu, Jinchun, et al.
Publicado: (2022) -
Overactivation of Norepinephrine–β2-Adrenergic Receptor Axis Promotes Corneal Neovascularization
por: Dong, Qiaoqiao, et al.
Publicado: (2023) -
Correction: Dapaglifozin reduces the vulnerability of rats with pulmonary arterial hypertension-induced right heart failure to ventricular arrhythmia by restoring calcium handling
por: Wu, Jinchun, et al.
Publicado: (2022) -
β-Adrenergic Receptor Stimulation Maintains NCX-CaMKII Axis and Prevents Overactivation of IL6R-Signaling in Cardiomyocytes upon Increased Workload
por: Matzer, Ingrid, et al.
Publicado: (2022) -
β-adrenergic blockade attenuates cardiac dysfunction and myofibrillar remodelling in congestive heart failure
por: Machackova, Jarmila, et al.
Publicado: (2011)